Market Overview:
The global nerve regeneration market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of neurological disorders, rising awareness about regenerative therapies, and technological advancements in the field of nerve regeneration. Based on type, the global nerve regeneration market is segmented into biomaterials, nerve conduits, and nerve protectors. The biomaterials segment is expected to account for the largest share of the global market in 2018. This segment is projected to grow at a CAGR of 8% from 2018 to 2030 due to its ability to promote cell proliferation and differentiation.
Product Definition:
Nerve regeneration is the process of repairing and restoring a nerve after it has been damaged. This can include regrowth of the nerve fibers, reconnection of the fibers to muscle or other nerves, and restoration of function. Nerve regeneration is important for restoring movement and sensation following an injury.
Biomaterials:
Biomaterials are materials derived from living organisms, which are used in the treatment of various neurological disorders. The most commonly used biomaterials for brain repair and replacement include scaffolds, hydrogels, nanofibers, and neural stem cells.
Nerve Conduits:
Nerve Conduits are used for the safe and rapid transmission of electrical signals from one place to another in the body. They are thin tubes made up of plastic or metal that carry an electric current from one nerve to another without any interruption. Nerve Conduits can be used for peripheral nerve repair, peripheral neuropathy treatment, spinal cord injury treatment and more.
Application Insights:
The others segment held the largest share of over 70.0% in 2017. The application includes research and clinical trials, which are majorly conducted in hospital settings. Increasing number of clinical trials for regenerative medicines is expected to drive the global nerve regeneration market over the forecast period. For instance, ULCA Regenerative Medicine Initiatives is a stem cell therapy clinic based at University Hospital Galway that offers Nerve Repair Service to treat patients with neuropathy caused due to diabetes or other causes (Alzheimer¢â‚¬â„¢s disease). This initiative was taken by this Irish hospital as part of its efforts toward becoming an international hub for stem cell research and treatment activities related to nerves and spinal cord injuries.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of companies involved in research and development activities. Moreover, increasing cases of neurodegenerative diseases such as Parkinson’s disease, Alzheimer's disease, and Huntington’s disease are expected to drive regional growth over the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period due to rising healthcare expenditure by governments along with an increase in awareness regarding various treatments for nerve disorders. The availability of skilled professionals at low cost coupled with increased demand from countries such as China and India is anticipated to boost regional growth soonest.
Growth Factors:
- Increasing incidence of neurological disorders: The global prevalence of neurological disorders is increasing at an alarming rate. This is primarily due to the aging population and the increased incidence of chronic diseases such as Alzheimer’s disease, Parkinson’s disease, and stroke. As a result, there is an increased demand for therapies that can help in the regeneration of nerve cells and tissues.
- Advances in stem cell technology: Stem cell therapy has emerged as a promising treatment option for various neurological disorders. It involves the transplantation of healthy stem cells into damaged areas of the brain or spinal cord to promote nerve regeneration. With advances in stem cell technology, this therapy is becoming increasingly more accessible and affordable.
- Growing investment in research & development: There is a growing investment by pharmaceutical companies in research & development for novel therapies that can promote nerve regeneration. This will help to bring about new products that are safe and effective for treating various neurological conditions .
Scope Of The Report
Report Attributes
Report Details
Report Title
Nerve Regeneration Market Research Report
By Type
Biomaterials, Nerve Conduits, Nerve Protectors
By Application
Hospital, Clinic, Others
By Companies
Pfizer, Bayer, Novo Nordisk, Takeda, SOBI, Octapharma, CSL Limited
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Nerve Regeneration Market Report Segments:
The global Nerve Regeneration market is segmented on the basis of:
Types
Biomaterials, Nerve Conduits, Nerve Protectors
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Bayer
- Novo Nordisk
- Takeda
- SOBI
- Octapharma
- CSL Limited
Highlights of The Nerve Regeneration Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biomaterials
- Nerve Conduits
- Nerve Protectors
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nerve Regeneration Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nerve regeneration is the process by which nerves regenerate after they have been damaged.
Some of the major companies in the nerve regeneration market are Pfizer, Bayer, Novo Nordisk, Takeda, SOBI, Octapharma, CSL Limited.
The nerve regeneration market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nerve Regeneration Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nerve Regeneration Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nerve Regeneration Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nerve Regeneration Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nerve Regeneration Market Size & Forecast, 2018-2028
4.5.1 Nerve Regeneration Market Size and Y-o-Y Growth
4.5.2 Nerve Regeneration Market Absolute $ Opportunity
Chapter 5 Global Nerve Regeneration Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Nerve Regeneration Market Size Forecast by Type
5.2.1 Biomaterials
5.2.2 Nerve Conduits
5.2.3 Nerve Protectors
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Nerve Regeneration Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Nerve Regeneration Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nerve Regeneration Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nerve Regeneration Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Nerve Regeneration Analysis and Forecast
9.1 Introduction
9.2 North America Nerve Regeneration Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Nerve Regeneration Market Size Forecast by Type
9.6.1 Biomaterials
9.6.2 Nerve Conduits
9.6.3 Nerve Protectors
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Nerve Regeneration Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Nerve Regeneration Analysis and Forecast
10.1 Introduction
10.2 Europe Nerve Regeneration Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Nerve Regeneration Market Size Forecast by Type
10.6.1 Biomaterials
10.6.2 Nerve Conduits
10.6.3 Nerve Protectors
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Nerve Regeneration Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Nerve Regeneration Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Nerve Regeneration Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Nerve Regeneration Market Size Forecast by Type
11.6.1 Biomaterials
11.6.2 Nerve Conduits
11.6.3 Nerve Protectors
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Nerve Regeneration Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Nerve Regeneration Analysis and Forecast
12.1 Introduction
12.2 Latin America Nerve Regeneration Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Nerve Regeneration Market Size Forecast by Type
12.6.1 Biomaterials
12.6.2 Nerve Conduits
12.6.3 Nerve Protectors
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Nerve Regeneration Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Nerve Regeneration Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Nerve Regeneration Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Nerve Regeneration Market Size Forecast by Type
13.6.1 Biomaterials
13.6.2 Nerve Conduits
13.6.3 Nerve Protectors
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Nerve Regeneration Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nerve Regeneration Market: Competitive Dashboard
14.2 Global Nerve Regeneration Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Bayer
14.3.3 Novo Nordisk
14.3.4 Takeda
14.3.5 SOBI
14.3.6 Octapharma
14.3.7 CSL Limited
